Desktop Metal - Q4 2020
March 15, 2021
Transcript
Speaker 0
Greetings, and welcome to Desktop Metals 4th Quarter and Full Year 2020 Financial Results Conference. At this time, all participants are in a listen only mode. A brief question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr.
Arjun Agarwal, Chief Product Officer. Thank you, sir. Please go ahead.
Speaker 1
Thank you, and thanks to everyone for joining us today for Desktop Metals' 4th quarter and full year 2020 earnings conference call. With me on the call are Rick Fulop, CEO, Chairman and Co Founder of Desktop Metal and James Haley, CFO of Desktop Metal. Earlier today, we issued a press release and made a slide presentation available on our Investor Relations website, which provides an overview of our business and financial highlights for the Q4 and full year 2020. This call is being webcast live on Desktop Metal's The content of today's call is the property of Desktop Metal. It can't be reproduced or transcribed without our prior written consent.
Before we begin, I would like to refer you to Slide 2 of our presentation, which contains our Safe Harbor disclaimer. Today's call will include forward looking statements. These forward looking statements reflect Desktop Metals' views and expectations only as of today, March 15, 2021, and actual results may vary materially based on a number of risks and uncertainties. For more information about the risk factors that may impact Desktop Metal's business and financial results, please refer to the Risk Factors section of the annual report on Form 10 ks that we filed with the SEC in addition to the company's prior filings with the SEC. We assume no obligation to update the forward looking statements.
Additionally, during this presentation or the following Q and A session, we may refer to non GAAP measures, including EBITDA and adjusted EBITDA. These measures are intended to supplement, but not substitute for performance measures calculated in accordance with GAAP. Our earnings release contains the financial and other quantitative information to be discussed today, as well as a reconciliation of the GAAP to non GAAP measures. With that, I'd like to turn it over to Rick.
Speaker 2
Thank you, Arjun. Good day, everyone. We're excited to welcome you to our first earnings call as a public company. The past several months has been transformational for Desktop Metal. In the Q4 alone, we completed the transaction between Trine and Desktop Metal, Started trading on the New York Stock Exchange and began shipping several new products, core to our long term roadmap, ending the year with over $595,000,000 on the balance sheet to fund our growth strategy.
I'd like to start today by providing an overview of our business for those that are new to our story, highlight some of the key milestones we achieved in the Q4 and discuss some of our strategy going forward. After my remarks, James will cover our evolution to a public company, discuss our financial results for the Q4 and full year 2020 and provide guidance for 2021. First, an overview of our business starting with our investment highlights on Slide 3. Desktop Metal is the only pure play additive manufacturing 2.0 company. We're pioneering a new generation of additive manufacturing technologies focused on the production of end use parts to help businesses make high performance products faster, more sustainably and at cost and volume competitive with conventional manufacturing processes.
The additive manufacturing market is a significant and growing opportunity that's expected to go from $12,000,000,000 in 2019 to about $146,000,000,000 by 2,030. This 11x growth is being propelled by a shift from prototyping and tooling into mass production applications. And the industry has strong secular tailwinds around on shoring and supply chain flexibility. We have a growing portfolio of additive manufacturing 2.0 solutions focused on volume production of end use parts that we think has industry leading price performance and capabilities across the portfolio with over 190 materials qualified across polymers, metals, ceramics, composites and biocompatible resins. Our products include some of the largest and fastest DLP systems in the market with the Envision 1 HD and the Extreme 8 ks.
We've got the fastest metal printer in the market with a production system P50. It's about 100 times faster than prior generation technologies like laser powder bed fusion. We've also got a series of developing businesses in composites and pipe fabrication that we're going to expand, as I'll discuss shortly. This portfolio is packed by differentiated technology modes. That includes printers, software, materials and over 2 60 patents issued or pending.
We have a second major moat around distribution, and we now have over 250 partners in 68 countries around the world. We're doubling down on a combination of horizontal and vertical focus for the channel to go after a variety of markets. We've got a solid dental and jewelry business and we'll continue to expand our focus into verticals such as healthcare, automotive, aerospace and oil and gas. We've got a very compelling financial profile. The products I highlighted earlier, each have high margin recurring revenue streams from consumables and service, which generate a multiple of the upfront revenue and gross profit over the lifetime of the system.
On the whole, we anticipate significant gross margin improvements and operating leverage as we scale revenue over time. And finally, we believe there's a significant inorganic upside potential in the business And we've got a team with experience executing transactions. We've ended the year with a very robust liquidity profile and we expect to use organic activities, but also generate a return as we add strategic capabilities to the business in line with a strategy focused on enabling killer apps for Additive. Taking a step back to look at the additive manufacturing industry as a whole on Slide 4. Today, A small percentage of the spend in the program goes to design prototypes, tooling and jigs and fixtures.
These use cases has traditionally been the focus of additive manufacturing. This actually used to be an industry called rapid prototyping, but the vast majority of the spending in a program really goes to the end use parts in production. Turning to Slide 5. To take additive manufacturing or AM to mass production, there's 4 key hurdles, Each has a high bar given the maturity of conventional manufacturing processes. In the polymer space, for example, surface finish has traditionally been a barrier.
Parts that look and feel like end use parts. Autopolymer AM has cleared this hurdle, but for a long time, the parts didn't have the required accuracy. Today, there are resins available that fully cure during printing. So you can achieve the finish and accuracy needed to go to market with AM Parts. Material properties is also a recent area of innovation with multi cure resins, which now enable making parts from materials that rival or exceed widely available thermoplastics.
And finally, feeds have gradually been increasing since about 2011, primarily through continuous printing, which we patented. And they are now reaching a point where you can use photopolymerium production in high volumes. The story is very similar in the metal side, where over time technology advances have cleared each of these bars. The key hurdle we at the M are now addressing The speed and cost, where throughput has historically limited the use of metal AM because parts and systems have not been cost effective. Turning to Slide 6.
We're focused on print processes with productivity that continues to improve over time, writing semiconductor scaling laws. In metals, we've got the fastest binder jetting systems in the market. The engine that drives the throughput is inkjet, which is doubling throughput every roughly 18 to 24 months for the past 20 years by improving nozzle density and droplet firing frequency. Whereas vector based print processes typically require more time or more cost to scale throughput, an area wide process that gains efficiencies over time like our proprietary single pass gating drives the economics of additive down the cost curve to make it competitive with conventional manufacturing at volumes up to 100 of 1000 of units per day And even larger volumes as a new generation print engine is introduced. On Slide 7, we see the same thing happening in photopolymers With the move to UV diodes as a light source for curing, EnvisionTek's photopolymer printers have scaled speed roughly every 24 months as new generations of diodes come out.
Now you've got their new patented approach called projection arrays, which multiplies improvements in power output, enables print speeds to scale even faster. Resolution has also had scaling with rapid advancements in underlying image projection technology. This allows you to have larger build platforms with more parts. The result of all this is that our photopolymer printers can now use these improvements in power and With this focus on technologies that ride third party improvements in efficiency and power, we have the win behind our sales We anticipate growing more competitive with conventional manufacturing each year. Turning to Slide 8.
Added Manufacturing 2.0 or AM 2.0 represents this next generation of technologies that enables volume production of end use parts With finish, accuracy, properties and economics that are actually competitive with conventional manufacturing. The AM market has compounded at 20% annually over the last decade to $12,000,000,000 by 2019. In the last 3 years before 2019, it actually compounded at 25% annually. We think the market overall exhibited a strong bounce back from COVID-nineteen in the Q4 and that points to a promising year ahead. And the industry is expected to continue to compound at roughly 25% over the next decade to get to $146,000,000,000 by 2,030.
This inflection is really being driven by more and more businesses shifting towards end used parts powered by AM 2.0. And that $146,000,000,000 only represents 1% penetration of the overall $12,000,000,000,000 the global manufacturing industry. So there's plenty of room to continue to grow. Turning to Slide 9. The reason so many are looking to use additive for end use parts as it eliminates the need for tooling, which has created significant pain points in conventional manufacturing.
For example, Long lead times, minimum volume requirements, time sensitive machine programming and significant material waste. Conventional manufacturing also creates design limitations that can negatively impact performance and cost in favor of manufacturability. Additive enables benefits like the ability to design complex parts using generative design tools that optimize for real world physics or assembly consolidation, which takes many components and prints them as a single part with dramatic efficiencies and weight or performance or mass customization of parts to particular markets or environments or finally, reengineering supply chains around the On Demand, flexible manufacturing capacity in digital inventories where businesses ship files across borders for local manufacturing. There's a dramatic opportunity to reshape global commerce and improve CO2 footprints as we develop more efficient ways to mass produce and ship products to consumers, And these are key long term tailwinds for AM 2.0. I'd like to spend some time to highlight some exciting initial applications that are becoming cost effective with our AM 2.0 solutions.
In the past, you probably heard of additive being used for very high end, very low volume parts like jet engine components. I think one of the problems with Additive is it costs Home Patch to be used at scale in larger markets. One of the more exciting things about our solutions is that we can now use AM 2.0 technologies to make hundreds of thousands of parts in applications that you never would have considered using Additive for in the past. On Slide 10, you can see one of our customers, for example, a company called EAC in France. They're a major supplier of metal accessories for swimwear cosmetics and luxury goods for companies such as Chanel and Louis Vuitton.
More and more they're using our shop That is a fantastic, fantastic development for Additive. They received their system middle of last quarter and it's already making parts in high volume. The shop system helped EAC increase their leather hardware production from 10,000 pieces per week to more than 70,000 parts per week. Those are real manufacturing numbers, tens of 1,000 pieces per week. Shop System also allows them to create volume quantities of these accessories with significantly reduced lead times, which is important in the fashion industry and minimal to no manual assembly required.
This is a game changer for an SME business like this that supply an end use parts to a market. And it illustrates several core benefits of the SHOP system by energetics solution. Turnkey flexible manufacturing, Volume production of real end use parts with faster time to market and the ability to get up and running quickly with minimal prior biogenic experience. As a plug and play solution, it's extremely easy to install and deploy. On Slide 11, another exciting case study is with one of our P1 customers, Freeform Technologies.
They've got a very experienced team in Pennsylvania and are dedicating themselves to making parts with metal binder jetting. With the P1, the part quality and throughput has enabled them to continually gain business with their customers, fulfilling small quantities of parts at first and then growing to a large volume. And because it's a digital manufacturing process, they can economically turn around thousands of parts in 1 to 2 weeks versus 2 to 3 months with conventional manufacturing for older generation AM systems, a 75% to 90% reduction in lead time. On top of supporting direct material and process transfers to flagship production P50, the P1 is a great tool for high speed, serial production of small and complex parts. Turning to Slide 12.
Since the Q4, we also entered a fast growing photopolymer additive market with our acquisition of EnvisionTek, the original inventor of digital light processing or DLP printing, An areawide photopolymer 3 d printing process. We have significant blocking IP in this segment, which has bolstered our DM PAN portfolio. Together, we create a one stop shop for AM 2.0 solutions across polymers and metals. What we're excited about with EnvisionTek is that their solutions have been used to produce Endyus parts at scale with over 10,000,000 parts in 2020 alone. They're a market leader in fast growing segments like dental Our sales of their EnvisionOne platform grew over 3x in 2020 despite the challenges from COVID-nineteen.
EnvisionTek gives us a fantastic platform as we expand the business to reach a whole new set of verticals and applications that benefit from polymer parts and volume. And on top of this, we grow our channel in both number and geographic reach with great opportunity for cross selling metal and polymer solutions. Looking at the product portfolio as a whole on Slide 13, we feel it's the most compelling and diverse set of AM2.0 solutions in the market And it can cater to metals, composites, ceramics, photopolymers and even include digital casting and bioprinting capabilities. And what's great is that it can address use cases across our product life cycle from preproduction all the way to volume in used parts. This is a killer product lineup.
Almost all of these products have been refreshed and released within the last year, and we believe they can take us to significant scale. They're backed by a very strong IP portfolio of over 260 issued and pending patents and supported by a library of over 190 materials. To build these products, we really have to pioneer a set of disruptive technologies. On Slide 14 now, single pass jetting It's the patent pending technology that powers our production system platform. Unlike competitive binder jetting systems, which typically require 20 to 30 seconds to print a layer, The production system P1 and P50 can print a layer in under 3 seconds.
This equates to build speeds that are up to 100 times faster Simparabid Fusion is significantly faster than conventional binder jetting. The P50 can support production of up to millions of parts annually at costs that are competitive with conventional manufacturing at reasonable volumes. And this is really key because businesses won't adopt additive if it can't compete on cost. The production system platform offers the only inert processing environment in the market. So we're actually able to print reactive materials via binder jet.
As an example, we had great announcement last week on a breakthrough in the development of aluminum for binder jetting, where we've collaborated with our partners to achieve extremely promising Results of over 99% dense 6,061 aluminum material with properties better than rock with comparable heat treatment. On the metal side, we've also got advanced sensing technology we've developed in house to be affordable and easy to install. It makes binder jetting an accessible turnkey solution that can be adopted rapidly by businesses and individuals without experience with printing or metallurgy. Both of these technologies are enabled by LifeSinter, our proprietary sintering simulation software designed to improve part accuracy and eliminate the trial and error for powder metallurgy based additive manufacturing. It dynamically stimulates the sintering step of the binder jetting process to predict shrinkage and distortion and correct geometries before printing to minimize any deviations from the intended design of the final part.
This software too will be a key enabler for broader adoption of Biogen. Turning to Slide 15. On the photopolymer side, we have a unique patented technology in continuous digital light manufacturing. This is an extremely cost effective solution for mass production of photopolymer parts that uses proprietary domeless basement technology to provide higher accuracy prints than membrane alternatives. The Envision 1 HD, which began shipping in the Q1 of 2021, is the only commercially available high temperature, high viscosity photopolymer Shipping and volume today.
And we think this is the future in photopolymer AM. This technology allows businesses to achieve Properties on par or exceeding conventional thermoplastics. And these systems are doing extremely well. On the right here is the new Extreme 8 ks solution, which uses patented protection array technology to achieve native 8 ks resolution and effective 16 ks resolution at very high It's the most advanced polymerization system in the market compared to an industrial Fortis 450 FDM printer from Stratasys, the system is up to 100 times faster with a build envelope that's roughly the same size. And it offers superior price performance to comparable industrial polymeraim systems.
Just like the Envision 1 HD, it supports high temperature, high viscosity resins enable a wide variety of industrial commercial applications. Digging into our go to market on Slide We've got a leading global distribution network today with over 200 partners that can sell and service our solutions in over 68 countries around the world. Our partners address a wide variety of markets and include vertically focused players as well as the ones focused on general industrial businesses. They can support a variety of business models and product offerings, whether it's low touch high volume or high touch high value. We think this is one of the differentiating assets of DM as a company, and we believe this will be a key factor in accelerating our growth to achieve global scale and launch new products efficiently.
Turning to Slide 17. We've got a very broad adoption over AM 2.0 Technologies across a variety of industries in both polymers and metals, healthcare, automotive, aerospace, oil and gas in consumer products, diversified manufacturers and machine shops. We're excited to expand this user base to more blue chip customers and SMEs as we continue to run production and distribution of our newer solutions. Turning to Slide 18. The unit economics of these products are fantastic.
The two examples here are the production system P50 and the Extreme 8 ks. The lifetime revenue and gross profit of each system is a multiple of the initial sale, roughly 3x to $6,500,000 in the case of a P50 and upwards of 10x to $1,500,000 with the Extreme 8 ks. Recurring contribution comes from the sale of high margin consumables and services, which results in strong gross margin profiles over the life of the system. So they really demonstrate a pretty attractive razor razorblade model, where the initial sale generates a profit as well. Turning for a moment to our strategy related to inorganic growth on Slide 19.
There's an opportunity here as we continue to build out a strong distribution channel bring new technologies on the printer side that are focused on AM 2.0. There's a lot of innovation in the private sector and we look forward to adding new print capabilities to our company to enable a wider set of applications and use cases. And second vector for inorganic growth is materials, where we see a huge opportunity to benefit from vertical integration. We've already built vertically integrated structure for materials in the photopolymer side, where we also have an open certified materials business model to work with partners with unique materials outside our moat to offer validated third party solutions to customers. On the metal side, vertically integrating into advanced materials, difficult for conventional manufacturing, could uplift the lifetime value of a P50 customer by up to 2x to 6x.
The 3rd vector for inorganic growth is building a strong parts offering around killer apps for additive, where our focus is to incorporate businesses and segments with high margin, high barriers to entry. And you'll see more about our strategy in this area as the year progresses and we execute some of these transactions. We believe this can be very accretive to the company and which have been quick to adopt AM at scale. And we're going to focus on building go to market strategies around each of these segments. Hearing aids, for example, is an application that has almost fully crossed over into additive.
The same goes for jewelry where AM is used widely for creating lost wax molds for casting And now it's starting to be used for direct metal printing. Turning to Slide 20. Today, we are announcing the creation of a new business called Desktop Health focused on patient specific additive manufacturing solutions for the healthcare and dental markets. To help lead this initiative, we're bringing on board Mike Jafar, with a storied career at Evolus and Allergan launching some of the best known brands in the healthcare space. We feel there are commercial ready applications in dental, But there's also a lot of exciting potential in other untapped categories.
And we look forward to working with Mike and his team to develop solutions for these applications and bring them to the market using our DLP, high speed metal binder jetting in Bioplotter Solutions. Our vision here is that today you've got more than $85,000,000,000 of medical implants annually They're mostly produced in standard manufactured sizes. We think that's going to change over the next decade or 2 where most of these parts will become patient specific. That's a major opportunity for additive manufacturing across metals, polymers, ceramics and oil materials. On Slide 21, dental is one of the killer apps for additive manufacturing.
It's a segment that has been patient specific for some time now since every part is custom. It's a market that's both growing and adopting additive quite rapidly. However, with more than $30,000,000,000 in annual parts spend in dental, only a small percentage of that total is printed. Most dental parts today are still milled or made by hand in the lab. We see an excellent opportunity for additive to reach up 75% by 2025 and we plan to be a major enabler of AAM adoption in the ortho, lab and chairside dental markets.
Materials are key to enabling applications in this market. You can see how many different use cases for AM there are in polymers, metals and ceramics. We've got several materials that have either received FDA 510 clearance or are in process, including proprietary materials for permanent crowns and full arch implant dentures with industry leading performance. Turning on to Slide 22. We believe the future is through processes that take less time where you can remove the temporary setups.
An example is full large implant entrance, which is a procedure that today takes an average 3 weeks from beginning to end. Enabled by our breakthrough proprietary materials and combined with our high speed printers, We developed with our partners a revolutionary same day digital workflow for full large implant dentures. This new 3 d printed smile takes place in a single day under the comfort of IV sedation. And this will be one of several initial solutions that we'll bring to market with Desktop Health. Our materials and process have been tested in a clinical study conducted in coordination with Leading partners in the field and participation from roughly 900 patients since March 2000.
Since then, there have been no failures with our printed implant dentures And the results overall have been excellent. This application is part of roughly $4,000,000,000 dental implant market, where we feel There is potential to completely revolutionize how patients are treated. And this is all enabled by a combination of advanced materials in both metals and polymers With really high quality properties in AM Technologies suitable for ENGIE's part production, we look forward to building a best in class team in healthcare and dental to work with our partners in industry to bring patient specific solutions to the market at scale, not just in dental, but also across cardiology, Orthopedics, Ophthalmology, Dermatology and Plastic Surgery. Now turning to our 4th quarter business highlights on Slide 24. As I mentioned earlier, we made several key strides in the Q4 towards commercializing our AM 2.0 technology platform.
We started global shipments of our SHOP system, a mass market biodegradating solution for SMEs and machine shops. It's a full turnkey offering designed for flexible mid volume production. Based on published figures, in just one quarter in the market, Shop System became the number one selling binder jet system in terms of units. In addition, we began global shipments of our production system P1 solution, the entry level model for our production system platform. It's also a great proof point on our path to commercializing the production system P50 in the second half of twenty twenty one as they share the same technology architecture and corporate modules.
We're incredibly proud of our dedicated team of employees that helped us achieve these key product launches in spite of the Among our commercialization products, we gained adoption from key customers such Milwaukee Tool, Ford, Eaton, Pratt and Whitney and more. We also launched our sintering simulation software, Life Center, for the Center of Binder Jetting Solutions and received significant awards from the Department of Defense. We beefed up our Board of Directors with the addition of Scott Dussault as veteran CFO and Nigro used to be President of HPE's Printing and Imaging business. With that, I'll turn it over to James, who's going to discuss financial highlights. James?
Speaker 3
Thanks, Rick, and thanks again to everyone for joining us today. I'm James Haley, the CFO of Desktop Metal. I'm pleased for this opportunity to share Desktop Metal's financial results for the first time as a public company. I'll begin with a quick recap for 2021, which can be found on Slide 25. We announced a definitive business combination agreement with that in aggregate provided approximately $530,000,000 of net proceeds to our balance sheet.
The business combination was completed on December 9th and we began trading on the NYSE on 10th under the ticker symbol DM. Moving to our financial results for the Q4 and full year of 2020, We are pleased with our 4th quarter results, which reflect an inflection point in our business as we successfully commence shipments of several new products. We generated revenue of $8,400,000 for the Q4 of 2020, up from $2,500,000 in the 3rd quarter and in line with our expectation of sequential acceleration. Cost of sales in the 4th quarter was $10,000,000 resulted in gross margin of negative 20%. This represents a sharp improvement from the Q3 of 2020 as we began to scale revenue out of our fixed overhead costs as well as a shift towards higher margin products.
Net loss for the Q4 was $25,400,000 which includes increased G and A expenses related to our transaction with Trine and becoming a public company, including additional headcount for corporate functions, audit, legal, professional services and insurance. Looking at the year overall, revenue for fiscal 2020 was $16,500,000 Net loss and non GAAP adjusted EBITDA for the fiscal year were negative $90,400,000 a negative $73,500,000 respectively. We ended the year with a well capitalized balance sheet, including cash, Cash equivalents and short term investments of $595,400,000 as of December 31, 2020. On February 26, 2021, with more than 75% of the public warrants from the transaction with Trine already exercised, We announced redemption of the remaining outstanding public warrants. Through March 10, 2021,11,900,000 public warrants were exercised for cash, resulting in proceeds of $136,800,000 Looking ahead to 2021, With our robust capital position, we plan to hit the accelerator on growth and will continue to make substantial investments in both Organic and inorganic opportunities.
Over the past few months, we have significantly expanded our sales and marketing, Engineering and administrative teams to ensure we are well positioned to fast track organic growth. Further, we are building out internal M and A capabilities to support the multiple inorganic growth initiatives, which Rick spoke to earlier. For the full year 2021, we expect to generate revenue In excess of $100,000,000 including contribution from EnvisionTek, we plan to exit the year with Annualized revenue run rate of at least $160,000,000 with multiple product launches From the Q4 right in the rearview mirror and additional commercial launches this year with EnvisionTek Extreme 8 ks and Envision 1 HT in the first half and the Production System T50 in the second half, we anticipate sequential growth to be relatively modest in the first quarter followed by a more substantial acceleration beginning in the second quarter as various growth initiatives take effect following COVID and as these new solutions pick up steam. Turning to adjusted EBITDA. On a non GAAP basis, we expect this to be in the range of negative $50,000,000 to $60,000,000 as we continue to invest in organic and inorganic growth.
With that, I'll turn the call over to Rick. Rick?
Speaker 2
Thank you, James. We're excited to be engaging with our new public shareholders as we embark on this journey. We're building our business for the long term and our leadership team and Board are aligned with our public shareholders. We view our AM 2.0 platform as leading the way in empowering businesses to finally realize the promise of additive manufacturing, reengineered supply chains, localized production, Full design freedom and all at a competitive volume and cost. Increasingly, digital manufacturing landscape is going to Experience a massive transformation over the next decade, and we at Desktop Metal are thrilled to be at the forefront of this 4th industrial revolution.
With that, I'll conclude our prepared remarks. Thank you everyone for listening and for your support. James and I are now happy to take questions.
Speaker 0
Thank you. Ladies and gentlemen, the floor is now open for questions. Time. Our first question is coming from Shannon Cross of Cross Research. Please go ahead.
Speaker 4
Good morning. I was wondering, Rick, Looking back at the last, I guess, we're at 7 or 8 months now since you announced the transaction and guidance at that point, which I think was dollars 15,000,000 to $25,000,000 in revenue for 2020. Can you talk a bit about what headwinds you faced, What you're seeing from the market in terms of reception to some of the launches and just What's leading you to be a bit more cautious in Q1 with an expected ramp thereafter? Thank you.
Speaker 2
Hey, Shana, thank you for the question. I think we have great funnel that's building for our products. We didn't get to ship our shop system until probably Middle or second half of the fourth quarter and the traditional COVID Supply chain related things, so moving things around the world. But we did a global launch in all continents, which I think was a strategic thing for us to get going on our SHOP system. And we did that to prevent The potential limitations of different places that we didn't know whether they'd be locked down or not.
Overall, we're pretty happy with the results, given all of the traditional challenges that other companies faced Yes, to get products delivered around the world. And I think that as we come out of pandemic, We're going to see some great resurgence and people going back to their labs and manufacturing spaces to execute programs.
Speaker 4
And I guess I appreciate that, but I'm just trying to figure out and maybe if we think about Q1 and the ramp through the year, What sort of builds upon itself that shows the acceleration starting in Q2? And what are the sort of the key products we need to watch? Yes.
Speaker 2
I think it's a reflection of our file and how it's building right now. We've got a number exciting products, particularly the Envision 1 HD and Envision 1 system continues to pick up. We're pretty happy with the way studios continue to develop. Studio 2 is now starting And shop system continued acceleration on that and P1s as well. So It's the product that we've been describing.
I think as we go through The rest of the year, we will have a progression that's similar to what you see in our industry, which is Q2 and Q4 are probably the landmark quarters in additive and then Q1 is usually A refresh from beginning of the year. So that's just a reflection of how we feel the year is going to progress Based on our funnel and how things are coming along. Okay. And then I guess the one point
Speaker 3
that I would add on that too is we are Planning to launch Envision 1 HD, the Extreme 8 ks, we're seeing strong demand for those already. And certainly, we have the P50 system that will be coming out in the second half. So the pipeline is really developing from here. I mean, Rick touched on the headwinds for Q1, but what we see now, we're very optimistic about the remainder of the year.
Speaker 4
Okay, that's helpful. And then maybe if you can just talk a bit about from an expense perspective, where you're funneling some of the incremental dollars? How much of this is because of EnvisionTek? How much you talked about expanding your sales and marketing team?
Speaker 5
And then maybe how much of this is related to your new healthcare initiative? Thank you.
Speaker 3
Sure. Great question. I mean, certainly, as I stated In our prepared remarks, we're sitting on nearly $600,000,000 of dry powder. Really, we're trying to hit the accelerator on growth here And that's going to be achieved certainly with multiple organic and inorganic opportunities. We touched on with building out an internal M and A capability.
Certainly, our organic sales team, the EnvisionTech sales team, marketing, Continued efforts on research and development, looking at various cost down initiatives as well as future products And then all the integration of multiple opportunities we're looking at. I will add to certainly the public company Expenses were not something that was sort of contemplated in some of the numbers prior. Those numbers are certainly substantial. And when you look at our market cap, In particular, I mean insurance and various professional fees, registration fees, they're certainly substantial.
Speaker 5
Great. Thank you.
Speaker 0
Thank you. Our next question is coming from Greg Palm of Craig Hallum. Please go ahead.
Speaker 6
Yes, thanks. Good morning and congrats on all the achievements thus far. I guess maybe just Starting at a high level and I'm really looking at the product portfolio specific to desktop. But Help us understand, raking in order of importance, studio versus shop versus production. And I'm just kind of Curious if you think about timing for P50 and the launch, is that something that we should expect Some revenue contribution this year or is that more of a fiscal 2022 event?
Speaker 2
No. Definitely, we'll expect Some contribution will be 50 this year in the second half, and that continues to be on schedule. P1 and the SHOP system are important parts of our product portfolio as they are mass production systems as well as our shop system. Studio is a Product that has its niche, and we're very excited about our Studio 2. On the photopolymer side, the Envision 1 is very much It product, it is doing extremely well in the market and in the particularly in dental labs and several other segments.
Continue to see significant traction and adoption on it as well as our D4 ks for Chairside. And it's We think those products are fantastic. So we are planning to scale Extreme AK as the year goes on and Are excited about that ramp.
Speaker 6
Got it. And just going back to the commentary on the Q1 Assumptions, I guess I'm just a little bit confused still. So it sounds like in Q4, there were still some kind of COVID related headwinds and Maybe some push outs in terms of timing. I guess looking at the revenue guide, I thought maybe given some of those new product introductions Then obviously you've got contribution from EnvisionTek that revenue would have jumped or at least the guide that would have suggested a revenue jump More sequentially, I guess you haven't quantified what modest really means, but is it just a matter of timing and seasonality?
Speaker 3
Yes, you nailed it on the head. Certainly, Q1 is traditionally a challenging quarter for the entire industry, certainly, we experienced those challenges as well. We do have some of the COVID challenges going on as well. But really, as We are heading into Q2. We're feeling very good about Q2.
Speaker 6
Okay. Understood. And then last one, there were some M and A rumors floating around this last week. I don't expect you to address those reports specifically. But Given that you've just completed the acquisition of EnvisionTek, in terms of inorganic, how active you expected to be in the marketplace in terms of additional M and A?
Speaker 2
I mean, we've got a strategy we laid out earlier During our original roadshow and just reiterated, we plan to continue to be active in M and A. However, it is Something that we do selectively. We require things that give us new capabilities in either Print modalities for AM 2.0 or vertically integrating into materials or consumables that our systems use, particular in high volume production applications. And then on the parts side, we've got a strategy to Enabling the printing of difficult to manufacture materials, which requires specialized processing as well as killer apps were there significant IP or high margin markets. And so we're going to continue to execute that, and you'd see transactions in the future as we as that goes on.
I'd say, we looked at a lot of business opportunities. It's not uncommon for companies that just went through what we went through to see a lot of things. And so we're very selective in what we actually move forward with. But We're excited about the things that we've got in front of us and think we can do very accretive Transactions.
Speaker 6
Understood. All right. Appreciate the color. Thanks.
Speaker 2
Thank
Speaker 0
Our next question is coming from Josh Sullivan of The Benchmark Company. Please go ahead.
Speaker 7
Hey, good morning, Rick, James, Arjun. Congrats on the 1st public quarter here.
Speaker 3
Thank you.
Speaker 1
First on
Speaker 7
the launch Of Desktop Healthcare. How should we think of this vertical in the portfolio? Was it going to have a dedicated sales force? What's the go to market strategy here? And then maybe what are the 2 or 3 primary products we should be focusing on over the next year or so?
Speaker 2
Absolutely. So the healthcare opportunity is massive. Today, most parts that are used in healthcare are not patient specific with the exception Dentistry, we're traditionally made by hand for patients. So when you buy a graft or an implant, It's traditionally something that was produced in 4 or 5 or 10 sizes and then the surgeons trying to match it at the time of at the time of surgery. And I think that a decade or 2 from now, everything will be patient And based on imaging, probably with the exception of Trauma, which needs real time inventory.
But I think that presents A very unique opportunity to develop a core competency in the business, and we are building a world class Go to market team that's going to develop clear products as well as help our partners in the healthcare industry adopt this technology at scale. We are going to be very creative in the types of products that we're going to help our partners bring to market. And I'm excited to share those as we evolve it. But I think it's going to be a very vibrant part of our business, expect To be at least onethree of our business in the long run. So it's a great area where End use parts can do very well.
And I think you'll see the healthcare industry adopt additive at scale over the next decade.
Speaker 7
Thanks. And then maybe just one on the production system. With the launch of the P1, Can you just talk about how that's led to additional pipeline development for the P50? Just curious how those two systems are working together. And then maybe just what does like the what does the pipeline of the P50 look like at this point?
Speaker 2
Yes, it continues to grow. I think we have a great synergy between a P1 and P50. Most customers that buy a P1 In the long run, we want to have a P50, and so it's an on ramp to that platform. It was actually developed in concert with a major customer Who bought a P50 but need a P1 type machine in order to qualify materials and parts without having to get A P50 light machine sort of pulled from production in order to do a qualification of a component. So if you're go to mass produce, if you're a large company, you've got 10,000 SKUs, 5,000 SKUs that you'd want to print.
You need a platform To qualify those while you've got the large CapEx printing 20 fourseven. And that's how we see the synergy between those two architectures, settings or qualification that you're doing a P1 translate 100% To a P50, they have the same modules and the same inkjet systems, the same Recoating process. So it's a one to 1, and we validated that with some of our customers that have both Installed the beta of a P50 and I received the P1 and I think that Obviously, a P1 is a much smaller machine, so it's easier to install and deploy. But it's a great platform. It's going to help us mature The technology to the point where you've got high OEE by the time we deploy the P50 into the market later this year.
So we're excited about how those two systems Play together. Got it.
Speaker 7
And then just with regard to the EnvisionTek acquisition, subsequent Acquisitions you guys might do here. How do we think about the long term targets? I understand you don't want to update us every quarter, but you've got a lot of dry powder here To execute additional M and A, how should we think of those long term targets maybe versus some of these inorganic opportunities you're pursuing?
Speaker 2
I think there I mean, obviously, you'd have to update the models when we do transactions. Some of the companies we're going to acquire are more technically oriented, and there's sort of capabilities in the technology that would allow us to have future products. And some of them are Companies that have some scale like EnvisionTek in an installed base that we're then going to provide additional distribution or Help scale faster. So I think that it depends on the transaction, And we have several things that we're working on. So as we execute them, we'd love to Explain the opportunity and why we did what we did.
And then I think there's a great opportunity In bringing AM 2.0 Technologies into the market, one thing that I think is a focus of us is we're not going to do any acquisitions on So the tooling or jigs and fixtures or things that we would consider AM-1.0. I mean our market grew In sort of a rapid prototyping tooling type of world and our company is 100% focused On mass production of end used parts. So there's other folks that would like to claim that there's that it's the same thing, but there's sort of 2 ways Well playing this market. 1 is to take a technology that's off patent, for example, like FDM, and develop a more modern version of that for smaller markets like tooling and jigs and fixtures. Another one is to really tackle The issue of how do you go to mass production at scale with additive.
And we're 100% focused on what we call AM 2.0, which is the production of additive parts at Scale at a lower cost structure than conventional manufacturing and where the economics are the driver. So that's 100% the focus of the company All of our M and A strategies and execution focus is geared towards making additive cost effective. The systems cost too much today to bring to market and older technologies just not cost effective on a Cost per part basis. So the focus of the company is 100% on the combination of techniques that give you a combination of surface finish, Accuracy, material properties and throughput, so you can actually go to market with 3 d printing.
Speaker 3
The one point I would add is the first part
Speaker 2
of your question and that is
Speaker 3
the long term thesis is intact and we are doing everything we can to accelerate it responsibly. To highlight Rick's point, I mean, we're in the business acquiring long term technology that's really going to help us, not short term revenue and accretion. Hopefully, later this year, we'll be in a position to provide some updates on the longer term model. But as we sit here exiting Q1, We don't think it's the right time to do it.
Speaker 7
Got it. Appreciate the time. Thank you.
Speaker 0
Thank you. Our next question is coming from Noelle Dilts of Stifel. Please go ahead.
Speaker 5
Hi, guys, and thanks for taking my question. So this kind of ties into the last question, but I'm just trying to reconcile The 2021 EBITDA guidance with the guidance you were talking about at the time of the SPAC. And So I'm just trying to understand sort of as you look at that bridge, how much of that is coming from EnvisionTek versus some kind of continued headwinds associated With COVID, as we look from, I think, going from around roughly $31,000,000 loss, including some of those public company versus the guidance you provided today. Could you help me just understand how to think about that?
Speaker 3
Sure. So certainly the public company costs, as I Are substantially higher than I think what we first thought. Beyond that, I'd really view it as Investment in the business, I mean really as I stated with near $600,000,000 of dry powder, we could Essentially just go status quo
Speaker 2
and
Speaker 3
leave the funds in the bank earning near zero interest, but instead We're doing everything we can to accelerate some of those longer term financial targets. So that is really how I would be Thinking about it, in terms of EnvisionTek, no, that is not really a drain on EBITDA, if you will. It's a transaction that as I mentioned, our primary focus is to acquire good technology with EnvisionTek. We certainly got that. We did also get some good stable revenues and a healthy bottom line as well.
Really, it's more about accelerating the growth story.
Speaker 2
Okay. Okay. Just wanted
Speaker 5
to make sure I understood that. And then obviously at the time of the EnvisionTek acquisition, you talked a lot about the growth profile and how you're thinking about contributions. But maybe You could speak to just as you kind of worked more with the company and started integration, if there's any change in how you're About growth over say the next 5 years. And then kind of related to the last question, I understand you kind of said you're maybe not at a point where you could talk about the longer term business model, but maybe going back to the EBITDA question, if you'd be comfortable kind of talking about generally when you're thinking about maybe hitting a breakeven point or moving to profitability? Thanks.
Speaker 3
Sure. So as we think about contribution on the year and really we continue to integrate the businesses every We're really trying to leverage different sales channels and development strategies as we can. As I think about revenue for the full year, I would say roughly 60% as we sit today is going to be on the organic DM side with 40% That said, going forward, it's not something that we really plan to talk about is these products we're going to be fully and teams are going to be integrated to really maximize our sales, if you will. In terms of the longer term targets, we're not in a position to update those today other than to say they're We're doing what we can to really pull the timelines in.
Speaker 5
Okay. Thank you very much.
Speaker 0
Thank you. Our next question is coming from Jim Ricchiuti of Needham and Company. Please go ahead.
Speaker 8
Hi, thank you. Good morning. Just a question on your OpEx investments For 2021, I'm wondering does that contemplate expansion of your direct sales efforts? Just wondering also in terms of your partner network, the presentation references 200 partners. And I'm wondering if you Provide any color on what percent of that represents EnvisionTech and whether among The 200 partners, if there's much overlap, partners representing both DM and EnvisionTek?
Thanks.
Speaker 2
Yes. So we went from about 90 partners to over 200 when we did a transaction and Acquired, EnvisionTech. I'd say, we have a significant continued expansion in our go to market strategy And there's significant synergies between the channel that they had built in our channel. They had very successful vertical Integration into the or vertical channels into dental and jewelry, we're planning to leverage those as well as Help and Vision Tech get into the industrial markets, which is an area where they hadn't participated as much before. So Hopefully that answers the question.
Speaker 8
It helps. And then just again, Looking at the investments your plan for 2021 in OpEx, and I may have missed it, but I'm wondering if there's any flavor you Provide in terms of R and D versus sales and marketing and enhancing the go to market?
Speaker 2
Well, I'd say that we have increased investment in a variety of areas. Besides R and D, we also have Thanks a lot.
Speaker 0
Thank you. At this time, I'd like to turn the floor back over to management for any additional or closing comments.
Speaker 2
I'm very excited to be talking to you all and look forward to connecting with you post this call anybody has additional questions, thank you very much for your support to date, and we're excited to be bringing additive manufacturing solutions at scale to mass produce parts and volume and change the way people make products around the world.
Speaker 3
Thank you. Have a great day.
Speaker 0
Ladies and gentlemen, thank you for your participation and interest in Desktop Metal. You may disconnect your lines and log off the webcast at this time and have a wonderful day.